期刊文献+

石榴叶鞣质中短叶苏木酚在大鼠体内药代动力学变化 被引量:9

Determination and pharmacokinetic study of brevifolin in rat after ig administration of pomegranate leaf extract
下载PDF
导出
摘要 目的建立测定短叶苏木酚血药浓度的高效液相色谱方法,探讨大鼠ig石榴叶鞣质后体内短叶苏木酚动力学变化。方法色谱条件依利特Hypersil色谱柱;流动相为乙腈-5mmol·L-1磷酸二氢钾溶液(pH25;86∶14,V/V);流速10ml·min-1;紫外检测波长为276nm,以短叶苏木酚峰面积定量。结果短叶苏木酚在176~880μg·L-1内线性良好,回归方程为^Y=393E5X+182E3(n=5),相关系数r2=09994,血浆中最低检测浓度为176μg·L-1。其352,176,880μg·L-13个浓度的回收率>85%,日内日间变异<7%。大鼠ig石榴叶鞣质后短叶苏木酚体内吸收、分布及消除均较快,符合二室开放模型。结论短叶苏木酚可以部分的反映了石榴叶鞣质的药代动力学特征。 Aim To develop a sensitive, simple and accurate method for quantification of brevifolin, one of the bioactive components of pomegranate leaf extract,in rat plasma following ig administration of extract by reversed phase high performance liquid chromatography.Methods The calibration curve for brevifolin was linear (r2=0.9994) over the concentration range 17.6~880 μg·L^-1 .At this concentration range, the method of overall recoveries (85%~94%) for brevifolin was constructed and the intra-and inter-day assays from rat plasma were less than 7%.Results Following oral administration of pomegranate leaf extract 0.8 g·kg^-1 ,the concentration-time profile was fitted with an open two-compartment system with lag time and the max concentration of brevifolin in plasma of 132 μg·L^-1 at 24.4 min.The pharmacokinetic profile indicates that brevifolin has the similar kinetic characteristics to ellagic acid, including rapid absorption,distribution and elimination.Conclusion This reverse HPLC is suitable for determining brevifolin in plasma.
出处 《中国药理学通报》 CAS CSCD 北大核心 2005年第3期369-372,共4页 Chinese Pharmacological Bulletin
基金 清华大学科技开发项目资助项目(No2002162)
关键词 短叶苏木酚 石榴叶 HPLC 药代动力学 brevifolin pomegranate leaf extract HPLC pharmacokinetics
  • 引文网络
  • 相关文献

参考文献15

二级参考文献34

  • 1熊程亿,施绪保,代宗顺,方达超.~3H-小檗碱在家兔及小鼠体内的药代动力学研究[J].中国药理学通报,1989,5(5). 被引量:27
  • 2盛美萍,孙淇,王宏.盐酸小檗碱在Beagle狗静脉注射和口服药动学研究[J].中国药理学通报,1993,9(1):64-67. 被引量:52
  • 3姬广臣,赵鲁鸣,王世军,史仁华,吴富东.针刺对大脑中动脉阻断大鼠软脑膜微循环血流量影响的实验研究[J].山东中医学院学报,1996,20(6):394-395. 被引量:6
  • 4毛凤斐 屠锡德.黄芩苷人体内吸收研究[J].中成药研究,1981,(12):6-9.
  • 5陈奇.中药药理研究方法学(第1版)[M].北京:人民卫生出版社,1996.992-1011.
  • 6洪有采 余琛 张慧etal.高效液相法测定小鼠组织中的小檗碱[J].中国医药工业杂志,1991,(8):356-7.
  • 7Handler CM, Price RW, Geller EB, Adler MW. Effect of muselective opioid antagonists on MIP-1β and IL-1β-induced fever.Ann NY Acad Sci, 1998 ;856: 270- 3.
  • 8Batra J K, Venkitasubramanian TA, Raj HG. Drug metabolism in experimental tuberculosis I : Changes in hepatic and pulmonary monooxygenase activities due to infection. Eur J Drug Metab Pharmacokinet, 1987 ; 12(2) : 109- 14.
  • 9Acharya G, Crevoisier C, Butler T et al. Pharmacokinetics of ceftriaxone in patients with typhoid fever. Antimicrob Agents Chemother, 1994;38(10) : 2415 - 8.
  • 10Acharya GP, Davis TM, Ho M et al. Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever.J Antimicrobial Chemotherapy, 1997 ; 40 ( 1 ) : 91 - 8.

共引文献113

同被引文献137

引证文献9

二级引证文献77

;
使用帮助 返回顶部